Participants 129 187 5
advanced gastric or gastroesophageal cancer adenocarcinoma
Participants 221 290 4
For patients with advanced gastric or gastroesophageal cancer (AGGEC)
Participants 517 536 9
multinational trial
Participants 545 557 9
445 patients
